Protocol for Meal-time Administration of Exenatide for Glycaemic Control in Type 1 Diabetes Cases (The MAG1C trial): a randomised, double-blinded, placebo-controlled trial.
Nicklas Järvelä JohansenThomas Fremming DejgaardAsger LundTina VilsbøllHenrik Ullits AndersenFilip K Krag KnopPublished in: BMJ open (2018)
NCT03017352.